Incretins, pregnancy, and gestational diabetes

Dragana Nikolic, Khalid Al-Rasadi, Noor Al Busaidi, Khalid Al-Waili, Yajnavalka Banerjee, Khamis Al-Hashmi, Giuseppe Montalto, Ali A. Rizvi, Manfredi Rizzo, Tamima Al-Dughaishi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The number of pregnant women affected by gestational diabetes mellitus (GDM) is increasing among Caucasians, and East Asians. GDM also increases the risk for later advent of type 2 diabetes mellitus (T2DM), obesity, and cardiovascular disease in both women and their offspring. The underlying mechanism of GDM is not fully elucidated. Incretins such as glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP), have been suggested to have a role in maternal metabolism and weight as well as fetal growth. These hormones might be implicated in mechanisms that compensate for the increment in glycemia and insulin resistance seen during pregnancy, while other factors, such as heredity, environment and lifestyle, but also different race/ethnic background might also lead to the comorbid health problems. Some studies indicate that pregnancy is associated with a diminished GLP-1 response which is more prominently evident in women with GDM and normalizes after delivery. Postprandial GIP level seems to be unaffected by pregnancy, despite its increased level in GDM. On the other hand, the reduced incretin effect observed in GDM may represent a risk factor for obesity, T2DM and metabolic disorders even in the offspring of these women. Further investigations are needed to establish the exact role of incretins in pregnancy and gestational glucose intolerance.

Original languageEnglish
Pages (from-to)597-602
Number of pages6
JournalCurrent Pharmaceutical Biotechnology
Volume17
Issue number7
Publication statusPublished - Jun 1 2016

Fingerprint

Incretins
Gestational Diabetes
Pregnancy
Gastric Inhibitory Polypeptide
Glucagon-Like Peptide 1
Type 2 Diabetes Mellitus
Obesity
Heredity
Glucose Intolerance
Fetal Development
Insulin Resistance
Life Style
Pregnant Women
Cardiovascular Diseases
Mothers
Hormones
Weights and Measures
Health

Keywords

  • Gestational diabetes
  • Incretins
  • Obesity
  • Pregnancy
  • Type 2 diabetes

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Biotechnology

Cite this

Incretins, pregnancy, and gestational diabetes. / Nikolic, Dragana; Al-Rasadi, Khalid; Busaidi, Noor Al; Al-Waili, Khalid; Banerjee, Yajnavalka; Al-Hashmi, Khamis; Montalto, Giuseppe; Rizvi, Ali A.; Rizzo, Manfredi; Al-Dughaishi, Tamima.

In: Current Pharmaceutical Biotechnology, Vol. 17, No. 7, 01.06.2016, p. 597-602.

Research output: Contribution to journalArticle

Nikolic, D, Al-Rasadi, K, Busaidi, NA, Al-Waili, K, Banerjee, Y, Al-Hashmi, K, Montalto, G, Rizvi, AA, Rizzo, M & Al-Dughaishi, T 2016, 'Incretins, pregnancy, and gestational diabetes', Current Pharmaceutical Biotechnology, vol. 17, no. 7, pp. 597-602.
Nikolic, Dragana ; Al-Rasadi, Khalid ; Busaidi, Noor Al ; Al-Waili, Khalid ; Banerjee, Yajnavalka ; Al-Hashmi, Khamis ; Montalto, Giuseppe ; Rizvi, Ali A. ; Rizzo, Manfredi ; Al-Dughaishi, Tamima. / Incretins, pregnancy, and gestational diabetes. In: Current Pharmaceutical Biotechnology. 2016 ; Vol. 17, No. 7. pp. 597-602.
@article{54b1305e0d22472a9d28061e63cfd3bc,
title = "Incretins, pregnancy, and gestational diabetes",
abstract = "The number of pregnant women affected by gestational diabetes mellitus (GDM) is increasing among Caucasians, and East Asians. GDM also increases the risk for later advent of type 2 diabetes mellitus (T2DM), obesity, and cardiovascular disease in both women and their offspring. The underlying mechanism of GDM is not fully elucidated. Incretins such as glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP), have been suggested to have a role in maternal metabolism and weight as well as fetal growth. These hormones might be implicated in mechanisms that compensate for the increment in glycemia and insulin resistance seen during pregnancy, while other factors, such as heredity, environment and lifestyle, but also different race/ethnic background might also lead to the comorbid health problems. Some studies indicate that pregnancy is associated with a diminished GLP-1 response which is more prominently evident in women with GDM and normalizes after delivery. Postprandial GIP level seems to be unaffected by pregnancy, despite its increased level in GDM. On the other hand, the reduced incretin effect observed in GDM may represent a risk factor for obesity, T2DM and metabolic disorders even in the offspring of these women. Further investigations are needed to establish the exact role of incretins in pregnancy and gestational glucose intolerance.",
keywords = "Gestational diabetes, Incretins, Obesity, Pregnancy, Type 2 diabetes",
author = "Dragana Nikolic and Khalid Al-Rasadi and Busaidi, {Noor Al} and Khalid Al-Waili and Yajnavalka Banerjee and Khamis Al-Hashmi and Giuseppe Montalto and Rizvi, {Ali A.} and Manfredi Rizzo and Tamima Al-Dughaishi",
year = "2016",
month = "6",
day = "1",
language = "English",
volume = "17",
pages = "597--602",
journal = "Current Pharmaceutical Biotechnology",
issn = "1389-2010",
publisher = "Bentham Science Publishers B.V.",
number = "7",

}

TY - JOUR

T1 - Incretins, pregnancy, and gestational diabetes

AU - Nikolic, Dragana

AU - Al-Rasadi, Khalid

AU - Busaidi, Noor Al

AU - Al-Waili, Khalid

AU - Banerjee, Yajnavalka

AU - Al-Hashmi, Khamis

AU - Montalto, Giuseppe

AU - Rizvi, Ali A.

AU - Rizzo, Manfredi

AU - Al-Dughaishi, Tamima

PY - 2016/6/1

Y1 - 2016/6/1

N2 - The number of pregnant women affected by gestational diabetes mellitus (GDM) is increasing among Caucasians, and East Asians. GDM also increases the risk for later advent of type 2 diabetes mellitus (T2DM), obesity, and cardiovascular disease in both women and their offspring. The underlying mechanism of GDM is not fully elucidated. Incretins such as glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP), have been suggested to have a role in maternal metabolism and weight as well as fetal growth. These hormones might be implicated in mechanisms that compensate for the increment in glycemia and insulin resistance seen during pregnancy, while other factors, such as heredity, environment and lifestyle, but also different race/ethnic background might also lead to the comorbid health problems. Some studies indicate that pregnancy is associated with a diminished GLP-1 response which is more prominently evident in women with GDM and normalizes after delivery. Postprandial GIP level seems to be unaffected by pregnancy, despite its increased level in GDM. On the other hand, the reduced incretin effect observed in GDM may represent a risk factor for obesity, T2DM and metabolic disorders even in the offspring of these women. Further investigations are needed to establish the exact role of incretins in pregnancy and gestational glucose intolerance.

AB - The number of pregnant women affected by gestational diabetes mellitus (GDM) is increasing among Caucasians, and East Asians. GDM also increases the risk for later advent of type 2 diabetes mellitus (T2DM), obesity, and cardiovascular disease in both women and their offspring. The underlying mechanism of GDM is not fully elucidated. Incretins such as glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP), have been suggested to have a role in maternal metabolism and weight as well as fetal growth. These hormones might be implicated in mechanisms that compensate for the increment in glycemia and insulin resistance seen during pregnancy, while other factors, such as heredity, environment and lifestyle, but also different race/ethnic background might also lead to the comorbid health problems. Some studies indicate that pregnancy is associated with a diminished GLP-1 response which is more prominently evident in women with GDM and normalizes after delivery. Postprandial GIP level seems to be unaffected by pregnancy, despite its increased level in GDM. On the other hand, the reduced incretin effect observed in GDM may represent a risk factor for obesity, T2DM and metabolic disorders even in the offspring of these women. Further investigations are needed to establish the exact role of incretins in pregnancy and gestational glucose intolerance.

KW - Gestational diabetes

KW - Incretins

KW - Obesity

KW - Pregnancy

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84974663230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84974663230&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 597

EP - 602

JO - Current Pharmaceutical Biotechnology

JF - Current Pharmaceutical Biotechnology

SN - 1389-2010

IS - 7

ER -